ENTPD1 and COVID-19: IL-6 induces CD39 expression on tumor infiltrating NK cells and might participate to their impaired functions in the context of cancer.7 Expression of CD39 on NK cells from COVID-19 patients may thus be explained by the levels of circulating IL-6 that rise with disease severity.